Literature DB >> 7307347

Generation of a soluble immune response suppressor factor (IRSF) by unstimulated leukocytes of healthy subjects.

M M Lederman, J J Ellner, H M Rodman.   

Abstract

Supernatants derived from unstimulated cultures of mononuclear leucocytes obtained from healthy subjects contained a factor(s) which consistently suppressed lymphocyte proliferative responses to antigens and mitogens. This factor(s) is produced by a non-adherent cell and was generated in vitro after 4 hr of culture. Cells from almost all healthy subjects produced this substance(s). Cell number and viability were not affected by it. Kinetic studies suggested that interference with antigen presentation was not the mechanism of its action. The release of this immune response suppressor factor(s) (IRSF) was not blocked by indomethacin and its biological activity was unrelated to levels of prostaglandin E2. Experiments with low-specific-activity thymidine showed that suppression was not due to release of unlabelled nucleotide. Preliminary characterization of IRSF revealed that it is heat-stable and partially dialysable through membranes with an exclusion size of 12,000 daltons. IRSF differs from previously reported soluble suppressor substances and may play a role in immunoregulation in health.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7307347      PMCID: PMC1537236     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  21 in total

1.  Interference with the transmission of T cell-derived messages by macrophage membranes.

Authors:  W Ptak; K F Naidorf; R K Gershon
Journal:  J Immunol       Date:  1977-08       Impact factor: 5.422

2.  Inhibition of 3H-thymidine incorporation of lymphocytes by a soluble factor from macrophages.

Authors:  H G Opitz; D Niethammer; H Lemke; H D Flad; R Huget
Journal:  Cell Immunol       Date:  1975-04       Impact factor: 4.868

3.  Immunosuppression in man: suppression by macrophages can be mediated by interactions with regulatory T cells.

Authors:  J D Stobo
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

4.  Human suppressor T cells induced by concanavalin A: suppressor T cells belong to distinctive T cell subclasses.

Authors:  T Sakane; I Green
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

5.  Biological expressions of lymphocyte activation. V. Characterization of a soluble immune response suppressor (SIRS) produced by concanavalin A-activated spleen cells.

Authors:  T Tadakuma; A L Kühner; R R Rich; J R David; C W Pierce
Journal:  J Immunol       Date:  1976-07       Impact factor: 5.422

6.  Enhanced binding of neuraminidase-treated sheep erythrocytes to human T lymphocytes.

Authors:  M S Weiner; C Bianco; V Nussenzweig
Journal:  Blood       Date:  1973-12       Impact factor: 22.113

7.  IgG on lymphocyte surfaces; technical problems and the significance of a third cell population.

Authors:  R J Winchester; S M Fu; T Hoffman; H G Kunkel
Journal:  J Immunol       Date:  1975-04       Impact factor: 5.422

8.  Prostaglandin-producing suppressor cells in Hodgkin's disease.

Authors:  J S Goodwin; R P Messner; A D Bankhurst; G T Peake; J H Saiki; R C Williams
Journal:  N Engl J Med       Date:  1977-11-03       Impact factor: 91.245

9.  Stimulation of lymphocytes by purified protein derivative: suppression by cells from human vaccinated with Bacille Calmette-Guérin.

Authors:  C Bona; L Chedid
Journal:  J Infect Dis       Date:  1976-04       Impact factor: 5.226

10.  Suppressor cell function in sarcoidosis.

Authors:  J S Goodwin; R DeHoratius; H Israel; G T Peake; R P Messner
Journal:  Ann Intern Med       Date:  1979-02       Impact factor: 25.391

View more
  2 in total

Review 1.  Human nonspecific suppressive lymphokines.

Authors:  M T Halpern
Journal:  J Clin Immunol       Date:  1991-01       Impact factor: 8.317

2.  Ovine concanavalin A-induced suppressor cells: generation, assay, age-related effects and re-evaluation of mechanism of suppression.

Authors:  J A Ellis; J C DeMartini
Journal:  Immunology       Date:  1985-02       Impact factor: 7.397

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.